Immunosuppressant therapeutic drug monitoring IVDs
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
10-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Roche Diagnostics Australia Pty Limited
Class:
Class 3
Manufactured by:
Roche Diagnostics GmbH Sandhofer Strasse 116, Mannheim, D-68305 Germany
Therapeutic area:
CT866 - Immunosuppressant therapeutic drug monitoring IVDs
Therapeutic indications:
In vitro diagnostic immunoassays for the quantitative determination of immunosuppressive agents in human whole blood. Includes quality controls and calibrators
Authorization status:
A
Authorization date:
2013-10-25
